Open Label, Non-Randomized, Phase 2 Study Investigating the Effect of RAD001 Monotherapy in Patients With Advanced NSCLC Previously Treated With Either Chemotherapy Only or With Chemotherapy and EGFR Inhibitor(s).
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Everolimus (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Oct 2008 Actual patient number reported as 85 by ClinicalTrials.gov.
- 13 Oct 2008 Official title amended as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from active, no longer recruiting to completed.